169 related articles for article (PubMed ID: 8320152)
1. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.
Ogilvie GK; Moore AS; Obradovich JE; Elmslie RE; Vail DM; Straw RC; Salmon MD; Klein MK; Atwater SW; Ciekot PE
J Am Vet Med Assoc; 1993 Jun; 202(11):1839-44. PubMed ID: 8320152
[TBL] [Abstract][Full Text] [Related]
2. Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors.
Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Curtis CR; Straw RC; Dickinson K; Cooper MF; Withrow SJ
J Am Vet Med Assoc; 1991 May; 198(9):1613-7. PubMed ID: 2061176
[TBL] [Abstract][Full Text] [Related]
3. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study.
Ogilvie GK; Moore AS; Chen C; Ciekot PA; Atwater SW; Bergman PJ; Walters LM
J Am Vet Med Assoc; 1994 Aug; 205(4):570-3. PubMed ID: 7961092
[TBL] [Abstract][Full Text] [Related]
4. Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors.
Ogilvie GK; Richardson RC; Curtis CR; Withrow SJ; Reynolds HA; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
J Am Vet Med Assoc; 1989 Dec; 195(11):1584-7. PubMed ID: 2599942
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of mitoxantrone against various neoplasms in dogs.
Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Straw RC; Dickinson K; Cooper MF; Withrow SJ
J Am Vet Med Assoc; 1991 May; 198(9):1618-21. PubMed ID: 2061177
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
Moore AS; Ruslander D; Cotter SM; Rand WM; L'Heureux DA
J Am Vet Med Assoc; 1995 May; 206(10):1550-4. PubMed ID: 7775231
[TBL] [Abstract][Full Text] [Related]
7. Hematologic and systemic toxicoses associated with carboplatin administration in cats.
Hahn KA; McEntee MF; Daniel GB; Legendre AM; Nolan ML
Am J Vet Res; 1997 Jun; 58(6):677-9. PubMed ID: 9185979
[TBL] [Abstract][Full Text] [Related]
8. A comparison of toxicity of two dosing schemes for doxorubicin in the cat.
Reiman RA; Mauldin GE; Neal Mauldin G
J Feline Med Surg; 2008 Aug; 10(4):324-31. PubMed ID: 18434224
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial and pharmacokinetic analysis of ifosfamide in cats with sarcomas.
Rassnick KM; Moore AS; Northrup NC; Kristal O; Beaulieu BB; Lewis LD; Page RL
Am J Vet Res; 2006 Mar; 67(3):510-6. PubMed ID: 16506919
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Ketoconazole for treatment of dermatophytosis in cats.
Medleau L; Chalmers SA
J Am Vet Med Assoc; 1992 Jan; 200(1):77-8. PubMed ID: 1537696
[TBL] [Abstract][Full Text] [Related]
12. Chloramphenicol toxicosis in cats.
Watson AD; Middleton DJ
Am J Vet Res; 1978 Jul; 39(7):1199-1203. PubMed ID: 567024
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy.
Cunha SC; Corgozinho KB; Souza HJ; Silva KV; Ferreira AM
J Feline Med Surg; 2015 Dec; 17(12):1000-4. PubMed ID: 25673018
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of (90)Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum.
Goodfellow M; Hayes A; Murphy S; Brearley M
J Feline Med Surg; 2006 Jun; 8(3):169-76. PubMed ID: 16442824
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.
Rassnick KM; Rodriguez CO; Khanna C; Rosenberg MP; Kristal O; Chaffin K; Page RL
Am J Vet Res; 2006 Mar; 67(3):517-23. PubMed ID: 16506920
[TBL] [Abstract][Full Text] [Related]
18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
19. Phenazopyridine toxicosis in the cat.
Harvey JW; Kornick HP
J Am Vet Med Assoc; 1976 Aug; 169(3):327-31. PubMed ID: 956020
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor evaluation of benzaldehyde in the dog and cat.
MacEwen EG
Am J Vet Res; 1986 Feb; 47(2):451-2. PubMed ID: 3954233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
